Shire dumps Dynepo.
Ratner
Mark
M
D001709:Biotechnology; D017277:Drug Approval; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics; D004921:Erythropoietin / Q000737:chemistry / Q000191:economics* / Q000378:metabolism; D005776:Gaucher Disease / Q000188:drug therapy; D005962:Glucosylceramidase / Q000191:economics; D019382:Human Growth Hormone / Q000191:economics; D008404:Massachusetts; D008958:Models, Molecular; D017467:Receptors, Erythropoietin / Q000737:chemistry / Q000378:metabolism
D016568:Drugs, Generic; D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D019382:Human Growth Hormone; D005962:Glucosylceramidase